LHON Society

Views & Analysis

It’s hard to imagine suddenly losing your sight in your 20s, but that’s what happened to Richard Wheeler when he developed

Oncology

Roi Raz, CEO of ReBio Pharma, discusses injectable, bioresorbable sustained release delivery for ophthalmic therapeutics at LSX 2026.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.